Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Astute Analytica | PRODUCT CODE: 1804304

Cover Image

PUBLISHER: Astute Analytica | PRODUCT CODE: 1804304

US Smart Home Healthcare Market: By Technology, Products, Services, Application, Indication - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025-2033

PUBLISHED:
PAGES: 140 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1800
PDF & Excel (Multi User License)
USD 2800
PDF, Excel & PPT (Corporate User License)
USD 3400

Add to Cart

The US smart home healthcare market is undergoing a seismic transformation, driven by an urgent demand for personalized and preventative care, fueled by aging demographics and rising chronic illness rates. Valued at US$ 8.48 billion in 2024, the market is poised for explosive expansion, projected to reach US$ 65.46 billion by 2033 at a CAGR of 25.30%. This acceleration reflects a strategic shift from institutional care settings to home-based solutions, where connected devices and platforms empower patients while optimizing healthcare delivery efficiency.

The aging population is a defining catalyst. With the number of Americans aged 65+ set to reach 77 million by 2034, smart technologies are becoming essential for enabling safe and independent living. Falls alone account for 36 million incidents among seniors annually, prompting widespread deployment of safety devices-over 2.7 million fall detection units have already been adopted. These devices are increasingly part of broader, interoperable home health systems, leveraging data from wearable sensors and AI-powered applications to manage conditions in real-time.

As the traditional healthcare system faces capacity constraints and cost pressures, smart home solutions offer a compelling alternative. Remote patient monitoring (RPM), nutrition tracking, memory support, and health status alerts are converging into intelligent ecosystems that not only detect health risks but actively manage them. This evolution positions the home as a critical node in the national healthcare infrastructure.

Noteworthy Market Developments

The rapid adoption of remote healthcare services is evident. By 2025, over 71 million Americans are expected to engage with RPM platforms-up from just 23 million in 2020. This surge is supported by advancements in consumer health tech, including wearable biosensors, connected diagnostic kits, and mobile health applications. Nearly half of U.S. adults aged 50-80 have already purchased at-home medical tests, indicating rising comfort and familiarity with these tools.

Economic pressures are also catalyzing growth. Approximately 67% of older adults cite cost-of-living challenges as barriers to aging in place, prompting a shift to more affordable home-based solutions. Meanwhile, digital nutrition platforms are flourishing, with global user bases reaching 1.4 billion and broadening access to dietary management tools.

Medication adherence is also a focal point. Smart memory aids now play a critical role in reducing preventable hospitalizations-estimated at 25% of all U.S. cases-and addressing the staggering annual toll of 125,000 deaths from medication non-adherence. In short, smart healthcare solutions are not just augmenting care-they are redefining how, when, and where it occurs.

Core Growth Drivers

The surge in demand for home-centric care models is fueled by four intersecting forces: the rise of hospital-at-home programs, the emergence of fully integrated wellness ecosystems, heightened data privacy demands, and the emergence of technologies for informal caregivers.

Hospital-at-home services are enabling patients with complex conditions such as pneumonia and heart failure to receive acute care at home using smart kits with devices like pulse oximeters, digital thermometers, and connected tablets for telehealth. By 2025, these programs have been deployed by leading U.S. health systems, offering hospital-grade care with improved outcomes and higher patient satisfaction.

Simultaneously, the market is transitioning to seamless, interoperable solutions. Devices now share data across platforms-sleep quality tracked by a smart bed can trigger adjustments in lighting or be cross-referenced with activity levels-creating a rich, continuous stream of insight. AI plays a central role in synthesizing this data into actionable care plans.

Moreover, consumer trust is emerging as a key differentiator. Data protection, end-to-end encryption, and HIPAA-compliant protocols are now baseline expectations. In 2025, company reputation around privacy management has become essential to consumer acquisition and retention.

Finally, caregiver tech is bridging the gap for millions of informal caregivers. Real-time dashboards, alerts, and medication tracking tools are empowering families to support loved ones while preserving independence. These features are not only improving care delivery-they are strengthening emotional and logistical support for entire care networks.

Emerging Technology Trends

Smart home healthcare in the US is becoming increasingly AI-powered, with FDA support accelerating market readiness. In 2025, over 1,000 clinical AI algorithms had received clearance, with 221 of them approved in 2023 alone. This includes innovations like smartphone respiratory rate apps and enhanced MRI imaging software. Devices are becoming less invasive, more intelligent, and easier to integrate into daily routines.

Venture capital interest confirms this momentum. AI-powered RPM and chronic care startups raised nearly $1 billion from 2024 through mid-2025. Notable deals include CoachCare's $110 million raise and Nobi's €35 million Series B to expand fall detection smart lamps in U.S. care facilities. Meanwhile, private equity is driving vertical integration-merging innovative tech firms with legacy providers to create unified care solutions.

M&A activity is also robust. Teladoc's acquisitions of Catapult Health and UpLift signal renewed focus on virtual diagnostics and mental health. LifeMD's entry into women's health, through strategic acquisitions, reflects a broader "tapestry strategy" of assembling end-to-end care ecosystems under one brand.

Barriers to Optimization

Despite growth, challenges persist. Data fragmentation remains a concern as interoperability gaps between platforms and devices limit holistic care coordination. Consumer privacy expectations are rising, demanding continued innovation in data governance. And while fall detection and RPM devices are becoming standard, integration with legacy EHR systems is often incomplete, slowing full deployment.

Furthermore, some providers-such as Best Buy Health-have exited hospital-at-home segments due to profitability concerns, illustrating the complexity of aligning innovation with scalable business models. However, retail and tech giants like Amazon are deepening their healthcare investments through acquisitions, suggesting long-term confidence in the smart healthcare sector.

Detailed Market Segmentation

Market Segment Analysis

By Product Type, testing, screening, and monitoring products dominate the landscape with over 77% market share. These solutions are core to the shift from reactive to proactive care, offering accessible and reliable tools for at-home diagnostics. The FDA's aggressive regulatory support-averaging 20 new AI algorithm clearances monthly-is fueling continuous product innovation. With nearly half of the senior population already using home diagnostic tools and 21% of Americans expected to use VR headsets for therapeutic purposes by 2025, this segment is set for sustained expansion.

By Services, skilled nursing leads with 28.80% market share, enabled by the integration of virtual care platforms and RPM tools into traditional in-home nursing. Providers like Amedisys and LHC Group are redefining nursing by incorporating telehealth to manage complex comorbidities. Studies show telepsychiatry in skilled nursing facilities rose by 20.2% where technology was well integrated, and patient adherence with interventions like medication reminders improved from 74.9% to 91.3%.

By Indication, cardiovascular diseases and hypertension represent the largest focus, commanding over 24.50% of market share. These conditions are the most common and costly to manage, but smart monitoring is dramatically improving outcomes. Remote patient monitoring has slashed hospitalizations by 87% and mortality by 77% in certain cohorts. With over 3,400 Medicare beneficiaries enrolled in long-term RPM for hypertension in 2025 and engagement success rates exceeding 90%, this remains a high-value and high-impact segment.

By Application, health status monitoring is the largest and most vital segment, accounting for 68.90% of revenue. The growing popularity of hospital-at-home programs-approved at 391 healthcare facilities in 39 states by 2025-has validated this model. These programs reduce hospitalizations by up to 30% and save nearly $8,000 annually per patient. With patient confidence rising (56% believe they recover faster at home), the infrastructure for high-quality in-home acute care continues to expand rapidly.

Segment Breakdown

By Technology

  • Wired
  • Wireless

By Products

  • Testing, Screening and Monitoring Products
  • Therapeutic Products
  • Mobile Care Products

By Service

  • Skilled Nursing Services
  • Rehabilitation Therapy Services
  • Hospice and Palliative Care Services
  • Unskilled Care Services
  • Respiratory Therapy Services
  • Infusion Therapy Services
  • Pregnancy Care Services

By Application

  • Fall Prevention and Detection
  • Health Status Monitoring
  • Nutrition or Diet Monitoring
  • Memory Aids

By Indication

  • Diabetes
  • Respiratory Diseases
  • Pregnancy
  • Mobility Disorders
  • Hearing Disorders
  • Cancer
  • Wound Care

Geographic Insights

The United States leads globally in smart home healthcare innovation due to strong tech infrastructure, advanced health systems, and favorable regulatory frameworks. Urban and suburban areas are the epicenters of adoption, with institutional programs expanding into rural communities through federal grants and Medicaid-supported services.

Major regional health systems, such as Mount Sinai in New York, are scaling hospital-at-home models rapidly, and CMS reimbursement programs are extending coverage across 39 states. As more providers enter the space, regional disparities are expected to diminish, broadening market penetration across income and geography.

Leading Market Participants

Key players driving innovation and scale in the US smart home healthcare market include:

  • Apple Inc.
  • General Electric Company
  • Abbott Laboratories
  • AT&T Inc.
  • F. Hoffmann-La Roche Ltd
  • Fitbit Inc.
  • Siemens AG
  • Samsung Electronics Co. Ltd.
  • Qualcomm Technologies, Inc.
  • Medtronic
  • Koninklijke Philips N.V.
  • BSH Home Appliances Group
  • Resideo Technologies, Inc.
  • Schneider Electric SE
  • Other Prominent Players

Comprehensive Segmentation Framework

This report includes full segmentation by:

  • Technology: Wired, Wireless
  • Products: Testing, Screening and Monitoring Products, Therapeutic Products, Mobile Care Products
  • Service: Skilled Nursing, Rehabilitation Therapy, Hospice and Palliative, Unskilled Care, Respiratory Therapy, Infusion Therapy, Pregnancy Care
  • Application: Fall Prevention and Detection, Health Status Monitoring, Nutrition or Diet Monitoring, Memory Aids
  • Indication: Diabetes, Respiratory, Pregnancy, Mobility, Hearing, Cancer, Wound Care
Product Code: AA07251400

Table of Content

Chapter 1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

Chapter 2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents, By Region
  • 2.4. Assumption for the Study
  • 2.5. Market Size Estimation
  • 2.6. Data Triangulation

Chapter 3. Executive Summary: USA Smart Home Healthcare Market

Chapter 4. USA Smart Home Healthcare Market Overview

  • 4.1. Industry Value Chain Analysis
    • 4.1.1. Material Provider
    • 4.1.2. Manufacturer
    • 4.1.3. Distributor
    • 4.1.4. End User
  • 4.2. Industry Outlook
  • 4.3. PESTLE Analysis
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Suppliers
    • 4.4.2. Bargaining Power of Buyers
    • 4.4.3. Threat of Substitutes
    • 4.4.4. Threat of New Entrants
    • 4.4.5. Degree of Competition
  • 4.5. Market Dynamics and Trends
    • 4.5.1. Growth Drivers
    • 4.5.2. Restraints
    • 4.5.3. Challenges
    • 4.5.4. Key Trends
  • 4.6. Market Growth and Outlook
    • 4.6.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2033
    • 4.6.2. Price Trend Analysis
  • 4.7. Competition Dashboard
    • 4.7.1. Market Concentration Rate
    • 4.7.2. Company Market Share Analysis (Value %), 2024
    • 4.7.3. Competitor Mapping & Benchmarking
  • 4.8. Actionable Insights (Analyst's Recommendations)

Chapter 5. USA Smart Home Healthcare Market Analysis, By Technology

  • 5.1. Key Insights
  • 5.2. Market Size and Forecast, 2020-2033 (US$ Mn)
        • 5.2.1.1.1. Wired
        • 5.2.1.1.2. Wireless
        • 5.2.1.1.3.

Chapter 6. USA Smart Home Healthcare Market Analysis, By Products

  • 6.1. Key Insights
  • 6.2. Market Size and Forecast, 2020-2033 (US$ Mn)
    • 6.2.1. Testing, Screening and Monitoring Products
    • 6.2.2. Therapeutic Products
    • 6.2.3. Mobile Care Products

Chapter 7. USA Smart Home Healthcare Market Analysis, By Service

  • 7.1. Key Insights
  • 7.2. Market Size and Forecast, 2020-2033 (US$ Mn)
    • 7.2.1. Skilled Nursing Services
    • 7.2.2. Rehabilitation Therapy Services
    • 7.2.3. Hospice and Palliative Care Services
    • 7.2.4. Unskilled Care Services
    • 7.2.5. Respiratory Therapy Services
    • 7.2.6. Infusion Therapy Services
    • 7.2.7. Pregnancy Care Services

Chapter 8. USA Smart Home Healthcare Market Analysis, By Application

  • 8.1. Key Insights
  • 8.2. Market Size and Forecast, 2020-2033 (US$ Mn)
    • 8.2.1. Fall Prevention and Detection
    • 8.2.2. Health Status Monitoring
    • 8.2.3. Nutrition or Diet Monitoring
    • 8.2.4. Memory Aids

Chapter 9. USA Smart Home Healthcare Market Analysis, By Indication

  • 9.1. Key Insights
  • 9.2. Market Size and Forecast, 2020-2033 (US$ Mn)
    • 9.2.1. Diabetes
    • 9.2.2. Respiratory Diseases
    • 9.2.3. Pregnancy
    • 9.2.4. Mobility Disorders
    • 9.2.5. Hearing Disorders
    • 9.2.6. Cancer
    • 9.2.7. Wound Care

Chapter 10. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

Chapter 11. Apple Inc.

Chapter 12. General Electric Company

Chapter 13. Abbott Laboratories

Chapter 14. AT&T Inc.

Chapter 15. F. Hoffmann-La Roche Ltd

Chapter 16. Fitbit Inc.

Chapter 17. Siemens AG

Chapter 18. Samsung Electronics Co. Ltd.

Chapter 19. Qualcomm Technologies, Inc.

Chapter 20. Medtronic

Chapter 21. Koninklijke Philips N.V.

Chapter 22. BSH Home Appliances Group

Chapter 23. Resideo Technologies, Inc.

Chapter 24. Schneider Electric SE

Chapter 25. Other Prominent Players

Chapter 26. Annexure

  • 26.1. List of Secondary Sources
  • 26.2. Key Country Markets - Macro Economic Outlook/ Indicators
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!